Migraine Trial, Recruiting NCT05903027 Sponsor: University of Florence Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT05903027
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with migraine without aura, migraine with aura, or chronic migraine, based on internationally recognised diagnostic guidelines (ICHD-III)
  • People who experience at least 3 migraine days per month
  • People who are able and willing to follow the study procedures as required
  • People who have kept a headache diary for at least the month before joining the study

Who may not be able to join:

  • People who have a medical reason that means they cannot take a type of medication called gepants (confirm with trial site)
  • People who have other health conditions or illnesses that, in the treating doctor's opinion, could affect how the study results are measured
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393896969606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Florence
Registry
ClinicalTrials.gov
Start date
15 June 2023
Est. completion
15 June 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Headache pain freedom at 2 hours post-dose during the first attack; Occurrence of treatment-emergent adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov